NASDAQ:DXCM
$116.18
(
1.56%
)
Friday, 31st Mar 2023
DexCom Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $106.16 | $123.14 | Friday, 31st Mar 2023 DXCM stock ended at $116.18. This is 1.56% more than the trading day before Thursday, 30th Mar 2023. During the day the stock fluctuated 2.05% from a day low at $114.52 to a day high of $116.87. |
| 90 days | $102.50 | $123.14 | |
| 52 weeks | $67.11 | $539.06 |
Historical DexCom prices
| Date | Open | High | Low | Close | Volume |
| 2023-03-31 | $115.02 | $116.87 | $114.52 | $116.18 | 2 084 407 |
| 2023-03-30 | $114.27 | $115.00 | $112.62 | $114.40 | 1 548 460 |
| 2023-03-29 | $114.83 | $115.75 | $113.07 | $113.96 | 1 559 891 |
| 2023-03-28 | $117.32 | $117.99 | $113.14 | $113.82 | 1 335 386 |
| 2023-03-27 | $115.75 | $117.95 | $115.04 | $116.07 | 1 571 439 |
| 2023-03-24 | $114.26 | $115.21 | $112.79 | $114.09 | 1 360 743 |
| 2023-03-23 | $116.26 | $116.87 | $113.32 | $114.50 | 1 918 670 |
| 2023-03-22 | $118.93 | $119.24 | $114.92 | $115.00 | 1 452 538 |
| 2023-03-21 | $117.60 | $119.29 | $116.74 | $118.98 | 1 706 280 |
| 2023-03-20 | $113.95 | $117.43 | $113.95 | $117.21 | 1 704 128 |
| 2023-03-17 | $114.50 | $115.45 | $113.06 | $113.93 | 2 623 503 |
| 2023-03-16 | $113.06 | $115.36 | $112.39 | $114.56 | 2 658 436 |
| 2023-03-15 | $112.08 | $114.33 | $111.19 | $113.72 | 1 893 105 |
| 2023-03-14 | $111.86 | $113.71 | $111.30 | $113.16 | 2 077 358 |
| 2023-03-13 | $106.27 | $112.94 | $106.16 | $110.66 | 1 971 252 |
| 2023-03-10 | $112.28 | $112.28 | $107.28 | $107.77 | 2 999 004 |
| 2023-03-09 | $113.26 | $116.65 | $111.87 | $112.08 | 3 221 966 |
| 2023-03-08 | $113.51 | $114.02 | $111.86 | $112.74 | 1 378 918 |
| 2023-03-07 | $113.24 | $115.38 | $112.12 | $113.81 | 2 304 666 |
| 2023-03-06 | $114.10 | $116.08 | $112.44 | $113.25 | 5 555 018 |
| 2023-03-03 | $120.53 | $123.14 | $119.89 | $122.92 | 2 770 974 |
| 2023-03-02 | $112.51 | $121.37 | $112.38 | $121.24 | 4 454 020 |
| 2023-03-01 | $110.51 | $111.31 | $109.32 | $110.76 | 1 855 984 |
| 2023-02-28 | $111.69 | $112.52 | $109.88 | $111.01 | 1 761 595 |
| 2023-02-27 | $110.98 | $111.68 | $109.02 | $110.58 | 1 528 444 |
| 2023-02-24 | $110.42 | $111.48 | $109.35 | $110.09 | 1 540 181 |
| 2023-02-23 | $111.61 | $112.10 | $109.35 | $111.87 | 2 627 028 |
| 2023-02-22 | $114.54 | $114.98 | $104.20 | $111.65 | 6 374 956 |
| 2023-02-21 | $113.59 | $114.79 | $112.79 | $114.01 | 2 406 558 |
| 2023-02-17 | $116.39 | $117.03 | $113.40 | $114.76 | 1 808 033 |
| 2023-02-16 | $118.49 | $119.39 | $117.08 | $117.26 | 1 579 957 |
| 2023-02-15 | $118.66 | $120.28 | $118.00 | $120.17 | 1 553 843 |
| 2023-02-14 | $117.50 | $119.79 | $116.62 | $118.55 | 1 995 654 |
| 2023-02-13 | $119.69 | $121.11 | $118.01 | $118.28 | 2 943 851 |
| 2023-02-10 | $112.65 | $120.00 | $111.21 | $117.89 | 6 373 602 |
| 2023-02-09 | $110.02 | $110.71 | $106.82 | $107.24 | 4 240 000 |
| 2023-02-08 | $109.50 | $110.90 | $108.74 | $109.84 | 1 917 436 |
| 2023-02-07 | $105.71 | $109.75 | $104.66 | $109.50 | 2 189 094 |
| 2023-02-06 | $108.09 | $109.07 | $106.44 | $106.73 | 1 793 817 |
| 2023-02-03 | $107.18 | $109.98 | $106.21 | $108.43 | 2 969 333 |
| 2023-02-02 | $109.17 | $110.50 | $106.59 | $108.03 | 3 312 529 |
| 2023-02-01 | $107.16 | $108.57 | $104.44 | $107.71 | 2 875 642 |
| 2023-01-31 | $106.06 | $107.56 | $105.74 | $107.09 | 2 088 169 |
| 2023-01-30 | $106.12 | $106.94 | $105.08 | $105.49 | 1 687 493 |
| 2023-01-27 | $106.36 | $107.74 | $105.04 | $106.72 | 1 428 168 |
| 2023-01-26 | $105.44 | $107.03 | $104.13 | $106.65 | 2 268 109 |
| 2023-01-25 | $103.75 | $105.05 | $102.50 | $104.00 | 3 753 187 |
| 2023-01-24 | $105.24 | $106.51 | $103.72 | $106.03 | 1 684 668 |
| 2023-01-23 | $107.86 | $108.86 | $106.00 | $106.40 | 2 818 245 |
| 2023-01-20 | $106.20 | $108.00 | $104.99 | $107.86 | 2 389 854 |
About DexCom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i... DXCM Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
